Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients.

A prospective randomized study was conducted to determine the efficacy of imipenem-cilastatin (hereafter referred to as imipenem) (500 mg four times daily) versus combination therapy for febrile neutropenic patients receiving either no prophylaxis or ciprofloxacin for prevention of infections. Combi...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Cornelissen, J J, de Graeff, A, Verdonck, L F, Branger, T, Rozenberg-Arska, M, Verhoef, J, Dekker, A W
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1992
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189424/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1503442/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.4.801
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!